Skip to Main Content

Author Details

Martin D McCarter
University of Colorado School of Medicine
1989
222
53
PMIDPaper TitleJournal TitlePublished Year
38030524National trends in technique use for esophagectomy: Does primary surgeon specialty matter?Surgery2024
38018276The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.Int J Cancer2024
34984995Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.Dis Colon Rectum2023
37894280The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors.Cancers (Basel)2023
37649964Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma.Mol Cell Oncol2023
37390222Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.Sci Immunol2023
37119966Social vulnerability is associated with increased postoperative morbidity following esophagectomy.J Thorac Cardiovasc Surg2023
37285095Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison with Historical Controls.Ann Surg Oncol2023
37270644Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity.Nat Commun2023
37133865Analysis of Time Between Skin Lesion and Lymph Node Biopsies and Lymph Node Metastasis in Patients With Melanoma.JAMA Netw Open2023
37294387ASO Author Reflections: Gastric Ischemic Preconditioning Prior to Esophagectomy: Laparoscopic Gastric Ischemic Preconditioning.Ann Surg Oncol2023
37355517ASO Visual Abstract: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls.Ann Surg Oncol2023
37292990A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset.bioRxiv2023
37292921The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors.bioRxiv2023
36623238Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations.JCO Precis Oncol2023
36587482Mucosal Ulceration in Gastrointestinal Stromal Tumor is an Independent Predictor of Progression-Free Survival.J Surg Res2023
36443554Barriers and Facilitators in Implementation of an Esophagectomy Care Pathway: a Qualitative Analysis.J Gastrointest Surg2023
36577613Minimally invasive surgery is associated with decreased postoperative complications after esophagectomy.J Thorac Cardiovasc Surg2023
36602514Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.Dis Colon Rectum2023
36453464Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma.J Surg Oncol2023
36378549Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.Clin Cancer Res2023
34561777ASO Author Reflections: Adjuvant Therapy for Stage III Melanoma With or Without Completion Lymph Node Dissection.Ann Surg Oncol2022
35830886Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2022
35565240BRAF Modulates Lipid Use and Accumulation.Cancers (Basel)2022
36578279Prognostic Impact of the Presence of Barrett's Esophagus and Intestinal Metaplasia on Esophageal Adenocarcinoma Survival.Foregut2022
36420277Follicular regulatory T cells eliminate HIV-1-infected follicular helper T cells in an IL-2 concentration dependent manner.Front Immunol2022
36351335NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.J Natl Compr Canc Netw2022
35952693Lipoma and Its Doppelganger: The Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma.Surg Clin North Am2022
36388647Glypican 1 promotes proliferation and migration in esophagogastric adenocarcinoma via activating AKT/GSK/β-catenin pathway.J Gastrointest Oncol2022
35880938Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.Cancer J2022
35013216GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.Nat Commun2022
34942200Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics.J Invest Dermatol2022
35028137Circulating CD8<sup>+</sup> mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients.Clin Transl Immunology2022
34537899Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.Ann Surg Oncol2022
32277371Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma.Dig Dis Sci2021
33655895Mediastinoscopy-assisted Transhiatal Esophagectomy (MATHE) in End-stage Achalasia and Gastric Bypass: Technique and Early Results.Surg Laparosc Endosc Percutan Tech2021
33866468ASO Author Reflections: Revisiting the Role of Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma.Ann Surg Oncol2021
33805904MAIT Cells: Partners or Enemies in Cancer Immunotherapy?Cancers (Basel)2021
33581731Reduced immune-regulatory molecule expression on human colonic memory CD4 T cells in older adults.Immun Ageing2021
33777751Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers.Front Oncol2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
33884489Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma.Ann Surg Oncol2021
34818131Intestinal microbial communities and <i>Holdemanella</i> isolated from HIV+/- men who have sex with men increase frequencies of lamina propria CCR5<sup>+</sup> CD4<sup>+</sup> T cells.Gut Microbes2021
34487965Implementation of Minimally Invasive Pancreaticoduodenectomy at Low and High-Volume Centers.J Surg Res2021
33992855Spontaneous regression of an extragonadal seminomatous germ cell tumor.Cancer Treat Res Commun2021
34348236Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors.J Natl Compr Canc Netw2021
33982952The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry.Am J Gastroenterol2021
34365090Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.Immunobiology2021
34117105Gut Bacteria Induce Granzyme B Expression in Human Colonic ILC3s In Vitro in an IL-15-Dependent Manner.J Immunol2021
33277184Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer.HPB (Oxford)2021
  • 1 - 50 of 222

Recommended Authors

Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 1
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 2009
Number of shared co-authors 1
The Ottawa Hospital Research Institute
Career Start Year 2002
Number of shared co-authors 1
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Stomatology Hospital, Zhejiang University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 2
University of Cincinnati College of Medicine
Career Start Year 1996
Number of shared co-authors 1
Stanford University
Career Start Year 1996
Number of shared co-authors 0
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 1
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 3
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 4
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 1
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 3
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 0
University of California San Diego
Career Start Year 1985
Number of shared co-authors 6
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 2
Queen's University
Career Start Year 1982
Number of shared co-authors 0

Collaborators

National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 27
University of Colorado Anschutz Medical Campus
Co-authored papers 23
University of Colorado School of Medicine
Co-authored papers 23
University of Colorado Anschutz Medical Campus.
Co-authored papers 16
University of Colorado Anschutz Medical Campus
Co-authored papers 10
University of Colorado
Co-authored papers 10
Co-authored papers 9
Co-authored papers 8
University of Colorado Anschutz Medical Campus
Co-authored papers 8
Co-authored papers 7
University of California
Co-authored papers 7
University of Colorado Anschutz Medical Campus
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
St Jude Children's Research Hospital
Co-authored papers 5
University of Colorado Anschutz Medical Campus.
Co-authored papers 5
Mount Sinai Hospital
Co-authored papers 5
Johns Hopkins University School of Medicine
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of Colorado
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
University of Colorado Anschutz Medical Campus.
Co-authored papers 4
University of Colorado Anschutz Medical Campus.
Co-authored papers 4
University of Colorado School of Medicine, University of Colorado Denver
Co-authored papers 4
Co-authored papers 4
Roswell Park Comprehensive Cancer Center
Co-authored papers 4
Huntsman Cancer Institute, The University of Utah
Co-authored papers 4
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Saint John's Cancer Institute at Saint John's Health Center
Co-authored papers 3
David Geffen School of Medicine at University of California los angeles
Co-authored papers 3